Europeiska unionen - svenska - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antineoplastiska medel - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Europeiska unionen - svenska - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastiska medel - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

bristol-myers squibb ab - amfotericin b - sugtablett - 10 mg - amfotericin b 10 mg aktiv substans; mannitol hjälpämne - amfotericin b

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

bristol-myers squibb ab - buspironhydroklorid - tablett - 10 mg - laktos (vattenfri) hjälpämne; buspironhydroklorid 10 mg aktiv substans - buspiron

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

bristol-myers squibb ab - buspironhydroklorid - tablett - 15 mg - buspironhydroklorid 15 mg aktiv substans; laktos (vattenfri) hjälpämne - buspiron

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

bristol-myers squibb ab - buspironhydroklorid - tablett - 5 mg - buspironhydroklorid 5 mg aktiv substans; laktos (vattenfri) hjälpämne - buspiron

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

bristol-myers squibb ab - cefadroxil (vattenfri) - pulver till oral suspension - 100 mg/ml - cefadroxil (vattenfri) 100 mg aktiv substans; sackaros hjälpämne; natriumbensoat hjälpämne - cefadroxil

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

bristol-myers squibb ab - cefadroxil (vattenfri) - kapsel, hård - 500 mg - laktos (vattenfri) hjälpämne; cefadroxil (vattenfri) 500 mg aktiv substans - cefadroxil

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

bristol-myers squibb ab - cefadroxilmonohydrat - tablett - 1 g - cefadroxilmonohydrat aktiv substans - cefadroxil

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

bristol-myers squibb ab - cefepimdihydrokloridmonohydrat - pulver till injektions-/infusionsvätska, lösning - cefepimdihydrokloridmonohydrat aktiv substans - cefepim